The expression and activity of indoleamine 2,3‐dioxygenase in LCs are implicated in the pathophysiology of herpetic eczema in AD patients, potentially serving as biomarkers for predicting the risk of AD progressing to EH or other viral comorbidities, as reported by Staudacher and team.105. This evidence concerns the gene IDO2 and Alzheimer disease.